Skip to content
10-Q

Quarterly Report

Raptor Pharmaceutical Corp

0001564590-16-018048

← back to feed
Filed
May 5, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 2, 2016 85.31M sh
Capex Q1 2016 · Mar 31, 2016 $307K
Capex Q1 2016 · Mar 31, 2015 $2.05M
Long Term Debt Q1 2016 · Mar 31, 2016 $48M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $132.04M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $157.35M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $134.54M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $149.61M
Stockholders Equity Q1 2016 · Mar 31, 2016 $78.35M
Stockholders Equity Q1 2016 · Dec 31, 2015 $117.19M
Current Liabilities Q1 2016 · Mar 31, 2016 $39.46M
Current Liabilities Q1 2016 · Dec 31, 2015 $38.9M
Total Liabilities Q1 2016 · Mar 31, 2016 $285.62M
Total Liabilities Q1 2016 · Dec 31, 2015 $302.3M
Current Assets Q1 2016 · Mar 31, 2016 $165.43M
Current Assets Q1 2016 · Dec 31, 2015 $181.4M
Total Assets Q1 2016 · Mar 31, 2016 $363.97M
Total Assets Q1 2016 · Dec 31, 2015 $419.49M
Rd Expense Q1 2016 · Mar 31, 2016 $14.02M
Rd Expense Q1 2016 · Mar 31, 2015 $16.55M
Net Income Q1 2016 · Mar 31, 2016 −$41.59M
Net Income Q1 2016 · Mar 31, 2015 −$19.68M
Operating Income Q1 2016 · Mar 31, 2016 −$36.14M
Operating Income Q1 2016 · Mar 31, 2015 −$14.66M
Gross Profit Q1 2016 · Mar 31, 2016 $23.14M
Gross Profit Q1 2016 · Mar 31, 2015 $16.73M